ANG-2, EGF, Endoglin, and CXCL4 expression were higher in HUVECs treated with hematoma-derived exosomes (EX-Hematoma group) compared to those treated with serum-derived exosomes (EX-Serum group) (Figure 4B). This evidence concerns the gene EGF and hematoma.